SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-256677
Filing Date
2017-08-14
Accepted
2017-08-14 08:05:35
Documents
3
Period of Report
2017-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d398015d8k.htm 8-K 15888
2 EX-99.1 d398015dex991.htm EX-99.1 52019
3 GRAPHIC g398015g22t94.jpg GRAPHIC 8288
  Complete submission text file 0001193125-17-256677.txt   80740
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 171027269
SIC: 2834 Pharmaceutical Preparations